Jasper Therapeutics, Inc. (JSPR) stock
JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$13.68+0.31 (+2.32%)
Close on Nov 13, 2026Market cap $455.20MP/E –Yield –
Jasper Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Jasper Therapeutics's price to book ratio was 293.3× on Nov 11, 2026, against 133.5× a year earlier. Over the last 5 years it ranged from 5.9× to 424.2×, with a median of 58.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 293.3× | +160.5 |
| 2025 | Dec 31, 2025 | 132.8× | +17.8 |
| 2024 | Dec 31, 2024 | 115.0× | +91.2 |
| 2023 | Dec 29, 2023 | 23.8× | +12.3 |
| 2022 | Dec 30, 2022 | 11.5× | −101.8 |
| 2021 | Dec 31, 2021 | 113.3× | – |
See a number that looks wrong?